Literature DB >> 9220161

T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection.

S A Sharma1, G G Miller, R A Peek, G Pérez-Pérez, M J Blaser.   

Abstract

For Helicobacter pylori, the hsp60 heat shock protein encoded by hspB is being considered as a potential candidate for subunit vaccines. We investigated the humoral and cellular responses to H. pylori hsp60 and its cross-reactivity with the homologous Mycobacterium bovis p65 protein and autologous human hsp60 protein. H. pylori-infected persons had significantly higher levels than uninfected persons of serum immunoglobulin G antibodies recognizing H. pylori hsp60, but not M. bovis p65 or human hsp60, as determined by enzyme-linked immunosorbent assay. In contrast, immunoblotting demonstrated cross-reactivity of H. pylori hsp60 with human hsp60. T-cell recognition of H. pylori hsp60 was found in both infected and uninfected subjects, and there was no recognition of human hsp60. T cells from infected and uninfected subjects that had been activated in response to H. pylori hsp60 or M. bovis p65 were phenotypically similar but appeared to secrete different levels of gamma interferon and interleukin-10. These results demonstrate an apparent difference in the epitopes recognized by the T and B cells responding to H. pylori hsp60 in H. pylori-infected persons. In contrast to the T-cell responses, which were highly variable in all subjects and showed no recognition of autologous proteins, a specific B-cell response that may have cross-reactivity to human hsp60 is evident in some infected subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220161      PMCID: PMC170547          DOI: 10.1128/cdli.4.4.440-446.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  44 in total

Review 1.  Helicobacter pylori and peptic ulcer disease.

Authors:  W L Peterson
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy.

Authors:  R M Strauss; T C Wang; P B Kelsey; C C Compton; M J Ferraro; G Perez-Perez; J Parsonnet; M J Blaser
Journal:  Am J Med       Date:  1990-10       Impact factor: 4.965

Review 4.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.

Authors:  C Wanidworanun; W Strober
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

6.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

Review 7.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

8.  Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori.

Authors:  R Karttunen
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

9.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

10.  Intrafamilial clustering of Helicobacter pylori infection.

Authors:  B Drumm; G I Perez-Perez; M J Blaser; P M Sherman
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

View more
  7 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Chaperonin 60 unfolds its secrets of cellular communication.

Authors:  Maria Maguire; Anthony R M Coates; Brian Henderson
Journal:  Cell Stress Chaperones       Date:  2002-10       Impact factor: 3.667

3.  Cellular immune responses in Helicobacter heilmannii infection: evaluation of the role of the host and the bacterium.

Authors:  S M S Cinque; D M M Queiroz; G A Rocha; T F Soares; A M M F Nogueira; A M C Faria; O A Martins-Filho; R Correa-Oliveira
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

4.  Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori.

Authors:  H Yamaguchi; T Osaki; M Kai; H Taguchi; S Kamiya
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Aggregatibacter actinomycetemcomitans GroEL protein promotes conversion of human CD4+ T cells into IFNγ IL10 producing Tbet+ Th1 cells.

Authors:  Tahsin Saygılı; Semih Can Akıncılar; Bünyamin Akgül; Ayten Nalbant
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

6.  IL12, IL10, IFNγ and TNFα Expression in Human Primary Monocytes Stimulated with Bacterial Heat Shock GroEL (Hsp64) Protein.

Authors:  Ayten Nalbant; Tahsin Saygılı
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

7.  Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach.

Authors:  Abeer Babiker Idris; Alaa B Idris; Manal A Gumaa; Mohammed Babiker Idris; Amanda Elgoraish; Mohamed Mansour; Dalia Allam; Bashir Mo Arbab; Nazar Beirag; El-Amin M Ibrahim; Mohamed A Hassan
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.